BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Acetaminophen
,
rs6983267
,
PDX1
,
T cell differentiation
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GRB7
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Superior cervical ganglion
Tongue
Ciliary ganglion
Placenta
Appendix
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bordetellosis
Middle East respiratory syndrome
Down syndrome
Anomaly of chromosome pair 21
Genodermatosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
GSK-3-inhibitor-II
4-hydroxyestradiol-17 beta
eplerenone
Gramicidin
Taxol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
BP1
POLD4
QPRT
GJB2
BECN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
Enhancing the Bioactivity of Bicyclic Peptides Targeted to Grb7-SH2 by Restoring Cell Permeability.
Direct Interaction between Calmodulin and the Grb7 RA-PH Domain.
Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance …
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Single Subject Neratinib in Bladder Cancer (NRR)
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ